30Jun

DiaSorin and Tecan to collaborate in new platform development

DiaSorin and Tecan Group have announced that they have agreed to collaborate in a development under which DiaSorin will make use of Tecan’s Fluent® Laboratory Automation Solution as its nucleic acid extraction platform. The new platform will be used in combination with the DiaSorin Liaison® MDX PCR system to provide the customer with a complete sample to result system for molecular diagnostics.

The Fluent platform, to be supplied through Tecan Partnering, will be optimized for use with DiaSorin extraction chemistry and automated PCR set up of the Liaison MDX 96-well disc. Fluent breaks new ground, delivering more capacity and increased speed. The platform provides exceptional precision, throughput and walkaway time.

Dr David Martyr, CEO of Tecan, commented: “We are delighted that DiaSorin has chosen the Fluent Laboratory Automation Solution as the basis for this new platform. The precision, speed and low volume liquid handling accuracy offered by the Fluent are ideal for molecular diagnostics applications.”

To learn more about Tecan’s OEM development capabilities, go to partnering.tecan.com

For more information please contact

Tecan Trading AG

Antonietta Allocca

Seestrasse 103, CH-8708 Männedorf

Tel  +41 (0)44 922 81 11, Fax +41 (0)44 922 81 12

info@tecan.com  www.tecan.com

About Tecan

Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2016, Tecan generated sales of CHF 506 million (USD 508 million; EUR 474 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191).

About DiaSorin

Headquartered in Italy and listed in the FTSE Italia Mid Cap Index, DiaSorin is a global leader in the In Vitro Diagnostics (IVD) field. For over 40 years the Company has been developing, producing and marketing reagent kits for IVD worldwide. Through constant investments in research and development, and using its own distinctive expertise in the field of immunodiagnostics to deliver a high level of innovation, DiaSorin offers today the broadest range of specialty tests available in the immunodiagnostics market and new tests in the molecular diagnostics markets, which identify DiaSorin Group as the IVD “diagnostics specialist”.

For more information, please visit www.diasorin.com

Related

Strategic Partnership for New Bladder Cancer Diagnostic Test in the UK

Alpha Laboratories Ltd. (Eastleigh, UK) is delighted to have been appointed as the exclusive distrib...

Read More >

IATA Compliant Transport for Streck Cell-free DNA Blood Collection Tubes

Streck Cell-Free DNA BCT® CE blood collection tubes allow isolation of high-quality cell-free DNA (c...

Read More >

OGT pushes forward hybridisation-based targeted sequencing

Oxford, UK – 25 May 2017. Oxford Gene Technology (OGT), The Molecular Genetics Company, has made se...

Read More >

Shift to Paradigm™ Low-Retention Tips

A New Standard of Excellence in Your Application

Read More >

New Advanced Pipetting Academy Makes You a Pipetting Master

For many years Alpha Laboratories and Sartorius have delivered a popular training programme covering...

Read More >

The TOPRA Annual Symposium

The TOPRA Annual Symposium is the largest forum for European regulatory professionals to meet up, di...

Read More >